Alternative microbial testing: a novel DNA-based detection system for specified microorganisms in pharmaceutical...

Area of Science:

• Microbiology
• Analytical Chemistry
• Pharmaceutical Science

Background:

• Microbial contamination in pharmaceuticals is a critical quality control concern.
• Conventional methods for detecting specified microorganisms can be time-consuming.
• European Pharmacopoeia (EP) and USP guidelines outline standard microbial testing procedures.

Purpose of the Study:

• To validate fluorescence-coupled PCR as an alternative method for detecting microbial contamination in pharmaceutical preparations.
• To compare the efficiency and reliability of PCR with conventional pharmacopoeial methods.
• To assess the method's suitability for proving the absence of specified microorganisms.

Main Methods:

• Quantification of specific DNA segments for Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae using fluorescence-coupled PCR.
• Validation of the analytical method for specificity, linearity, precision, and sensitivity.
• Comparison of PCR results with conventional microbial contamination tests on pharmaceutical batches.

Main Results:

• The PCR method demonstrated high specificity and linearity over a wide range (6-7 log intervals) with correlation coefficients above 0.99.
• High precision was observed in replicate determinations (RSD 0.39-1.53%) and between different tests (RSD 0.76-1.91%).
• Sensitivity ranged from 1-10 CFU without pre-enrichment, and 1 CFU after pre-enrichment, yielding equivalent results to conventional methods on cream batches.

Conclusions:

• Fluorescence-coupled PCR is a validated, reliable, and sensitive method for detecting specified bacteria in pharmaceutical preparations.
• The PCR technique offers a faster and more efficient alternative to conventional microbial testing methods.
• This advanced PCR approach can significantly improve the speed and efficiency of pharmaceutical quality control.